Feed REGMF
RE

RemeGen Co., Ltd.

REGMF · OTC

$10.93 +0.00% (+$0.00)
1M +14.57%
Market Cap ¥41.3B
P/E Ratio 7.14x
Div. Yield -
ROE 127.36%

Bulios Fair Price

$10.65

2.6% downside

Current Price

$10.93

Undervalued Fair Value Overvalued

According to Bulios Fair Price, REGMF is currently trading close to its fair value. How does it work?

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Piotroski F-Score Strong
7/9
Valuation
83 /100
Cheap
EV/EBITDA 7.97x
P/S 5.19x
P/B 4.96x
Growth
78 /100
Growing
Book val. growth 10.17%
Rev. growth 60.38%
FCF growth N/A
Profitability
100 /100
Strong
Net margin 72.71%
Op. margin 61.13%
FCF margin 54.67%
Quality
95 /100
Excellent
ROE 127.36%
ROA 58.71%
Asset turnover 0.81x
Debt
100 /100
Low
Current ratio 4.86x
Int. coverage 106.63x
Net debt/EBITDA -0.25x
Stability
34 /100
Moderate
Rev. volatility 22.62%
EPS volatility 101.11%
Profitable years 1

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about REGMF
Online

Sector

Healthcare

Industry

Biotechnology

CEO

Jian Min Fang

Employees

3,048

Headquarters

Yantai

Upcoming events

04 NOV

Earnings

Upcoming earnings report

49d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.